Vicarious Surgical Inc. WT
Vicarious Surgical Inc. WT (RBOT-WT) Stock Overview
Explore Vicarious Surgical Inc. WT’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
47.9M
P/E Ratio
-0.70
EPS (TTM)
N/A
ROE
-1.17%
RBOT-WT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Vicarious Surgical Inc. WT (RBOT-WT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.70 and a market capitalization of 47.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Adam David Sachs
123
78 Fourth Avenue, Waltham, MA
1970